Back to search

Article

Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognition

2023-11-04

Abstract excerpt

<h4>INTRODUCTION</h4> Plasma phosphorylated tau181 (p-tau181) associations with global cognition and memory are clear, but the link between p-tau181 with other cognitive domains and subjective cognitive decline (SCD) across the clinical spectrum of Alzheimer’s disease (AD) and how this association changes based on genetic and demographic factors is poorly understood. <h4>METHODS</h4> Participants were drawn from t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3974f16-13a8-528a-960d-f5a0aba4417b
DOI
10.1101/2023.11.03.23298051
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognitionDOI 10.1101/2023.11.03.23298051
Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults.Semantic proximity
Association between plasma phospho-tau181 and cognitive change from age 73 to 82: Lothian Birth Cohort 1936Semantic proximity
Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declinesSemantic proximity
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.Semantic proximity
APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.Semantic proximity
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based studySemantic proximity
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort studySemantic proximity
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease StagesSemantic proximity
CNS-selective plasma p-tau217 accurately captures Alzheimer’s disease pathology and progressionSemantic proximity
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s diseaseSemantic proximity
Select a neighboring publication to make it the new centre.